GSE202434 GSE202438 talazoparib 12 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE202434_GSE202438_talazoparib_12_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE202434_GSE202438_talazoparib_12_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE202434_GSE202438_talazoparib_12_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE202434_GSE202438_talazoparib_12_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 511

Gene

HOXD antisense growth-associated long non-coding RNA

Gene

MAGI2 antisense RNA 3

Gene

HERC2 pseudogene 9

Gene

AFAP1 antisense RNA 1

Gene

chromosome 6 open reading frame 47

Gene

long intergenic non-protein coding RNA 886

Gene

tektin 4 pseudogene 2

Gene

HOXC13 antisense RNA

Gene

C10orf88B (pseudogene)

  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    HOXD antisense growth-associated long non-coding RNA


  • Gene

    MAGI2 antisense RNA 3


  • Gene

    HERC2 pseudogene 9


  • Gene

    AFAP1 antisense RNA 1


  • Gene

    chromosome 6 open reading frame 47


  • Gene

    long intergenic non-protein coding RNA 886


  • Gene

    tektin 4 pseudogene 2


  • Gene

    HOXC13 antisense RNA


  • Gene

    C10orf88B (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.